Sidley Austin represented Victory Live in the transaction, and Lowenstein Sandler represented ZMC and Logitix. Victory Live announced its acquisition of Logitix, a ticket management solutions...
Victory Live’s Acquisition of Logitix
Portside’s Acquisition of Takeflite
Lowenstein Sandler represented Portside in the transaction. Portside, a leading innovator in software solutions for business and government aviation, announced its acquisition of Takeflite, a leading...
Cyabra Strategy’s $70 Million Merger Agreement with Trailblazer Merger Corporation I
Lowenstein Sandler represented Cyabra Strategy Ltd. on the deal. Tel Aviv-based Cyabra Strategy Ltd., an AI-powered solution for combating worldwide disinformation, announced the signing of a...
Octopus Deploy’s Acquisition of Codefresh
Lowenstein Sandler represented Codefresh Inc. in the transaction. Codefresh Inc. announced its acquisition by Octopus Deploy, an enterprise that streamlines Continuous Delivery (CD) pipelines and cloud-native...
Bansk Group’s $800 Million Inaugural Fund Closing
Kirkland & Ellis LLP advised Bansk Group on the deal. Bansk Group announced the final close of its inaugural fund, Bansk Fund I LP (the “Fund”), at $800...
WHP Global’s Strategic Partnership with Express, Inc.
Goodwin Procter advised WHP Global on the deal, while Kirkland & Ellis advised Express. WHP Global entered into a mutually transformative strategic partnership with Express, Inc. (NYSE:...
Stone Point Capital’s $210 Million Acquisition of Kessler Group Business
Truist Securities, Inc., CIBC World Markets Inc., BMO Capital Markets and Solomon Partners, L.P. acted as financial advisors to the Company and Baker Hostetler LLP and...
Recipharm’s Acquisition of Arranta Bio
Kirkland & Ellis represented Recipharm in the transaction. Recipharm, a global contract development and manufacturing organisation (CDMO) and a portfolio company of EQT, executed the acquisitions...
Recipharm’s Acquisition of Vibalogics
Kirkland & Ellis advised Recipharm on the deal. Recipharm, a global contract development and manufacturing organisation (CDMO) and a portfolio company of EQT, executed the acquisition of...
Kriya Therapeutics’ $100 Million Series B Financing
Goodwin Procter LLP advised Kriya Therapeutics on the deal, while Kirkland & Ellis advised Patient Square Capital. Kriya Therapeutics announced the closing of a $100 Million Series...